Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-12

Clinical Trial Update: Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder [NA]

View source ↗

Summary

Clinical trial comparing botulinum toxin A alone versus botulinum toxin A with hydrodistension for overactive bladder; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Overactive Bladder | NA | Status: TERMINATED | Results posted: 2018-12-12